Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 5Gastrointestinal 2Lymphoid 1

Conditions

Thrombocytopenia 1Jacobs syndrome 1Gastrointestinal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Oxaliplatin 780Fluorouracil 638Capecitabine 575Gemcitabine 478Leucovorin 459Bevacizumab 445Irinotecan 444Cisplatin 338Radiotherapy 283Cetuximab 252Paclitaxel 180S 1 (combination) 176pembrolizumab 173Docetaxel 156Drug Therapy 147Nivolumab 146sintilimab 143tislelizumab 131apatinib 131130-nm albumin-bound paclitaxel 128Folfox protocol 121durvalumab 119Albumin-Bound Paclitaxel 117camrelizumab 107lenvatinib 106Panitumumab 106regorafenib 102Surgical Procedures, Operative 102Sorafenib 99Radiation 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × avatrombopag × Gastrointestinal × Clear all
NCT05772546 2026-03-13

ACT-GI

Massachusetts General Hospital

Phase 2 Active not recruiting
60 enrolled
Gastrointestinal

Jacobs syndrome, Gastrointestinal Neoplasms

NCT06001567 2023-09-14

Avatrombopag for HCC Patients With Thrombocytopenia Who Intend to Undergo TACE and/or HAIC

Second Affiliated Hospital of Guangzhou Medical University

Phase 2 Unknown
30 enrolled
Classical hematologyGastrointestinal

Carcinoma, Hepatocellular, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡